Cases & investigations

Cases & investigations

BioAtla

Kaskela Law LLC announces that it is investigating BioAtla, Inc. (NASDAQ: BCAB) on behalf of the company’s investors.

Since February 2023, shares of BioAtla’s common stock have declined in value from a trading price of over $4.30 per share to a current trading price of approximately $2.50 per share, a decline of over 41% in value.

The investigation seeks to determine whether BioAtla and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties to the company’s shareholders.

BioAtla shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by completing the form on this page, for additional information about this investigation and their legal rights and options.

CONTACT:

KASKELA LAW LLC
Adrienne Bell, Esq.
[email protected]
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750

Submit Your Information

  • This field is for validation purposes and should be left unchanged.

Contact Us

  • This field is for validation purposes and should be left unchanged.